Harbor Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.2/10
Best for: lowest-cost compounded GLP-1 with a 12-month money-back guarantee
Price is where Harbor scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market. Plans include weekly medication, ongoing provider consultations, refill management, and free 48-hour discreet shipping. Physicians provide 24/7 access and dosage adjustments via secure patient portal. Post-program dietitian support included. LegitScript certified; 4.7-star rating with 10,000+ members; 12-month money-back guarantee. HSA/FSA eligible.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Harbor
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Harbor at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Harbor
Each dimension is scored algorithmically from Harbor’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
9.4/10At $99/mo, Harbor runs about 41% below the $169 median for GLP-1 providers.
Effectiveness25%
8.4/10Harbor offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.1/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.8/10Harbor's exact state footprint isn't published — confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.7/10Clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Harbor review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$149/mo across 2 dose/plan tiers — checked July 2026
- State pharmacy licensing & LegitScript status
- LegitScript certified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Harbor
We walked Harbor’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete an online health questionnaire (about 10 minutes).
- 2A licensed U.S. clinician reviews your information; consultation type varies by state.
- 3If approved, medication is dispensed and shipped to you.
- 4Physician check-ins and dose adjustments continue during treatment, with a structured supervised transition off medication.
- 5Dietitian-led nutrition support helps maintain results after treatment.
- Pricing shown up front: semaglutide starting at $99/month, tirzepatide starting at $149/month.
- Advertises no price increases, no hidden fees, and insurance not required.
- Medication is shipped to the patient; dietitian support included in all programs.
- 24/7 physician access offered via patient portal.
- No explicit refund or cancellation policy observed on the page.
Harbor customer support
- Phone
- +1 (332) 205-9094
GLP-1 medications Harbor offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Weekly compounded semaglutide injection. Verbatim: 'From $99/mo'. Bundled plan covers medication, provider consultations, refill management, and shipping.
Weekly compounded tirzepatide injection. Verbatim: 'From $149/mo'. Bundled plan covers medication, provider consultations, refill management, and shipping.
Ready to get started?
Plans and promotions change often — check Harbor's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
- LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ members
- 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
- 12-Month Money Back Guarantee if you don't reach your weight-loss goal
- HSA/FSA eligible; no hidden fees, no insurance billed
Watch-outs
- Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
- Dietitian support offered only post-program (maintenance phase), not during active treatment
- State-specific consultation types vary; nationwide availability unconfirmed for all states
- No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
- Newer brand; success rate and member counts are on-site claims, not third-party confirmed
Is Harbor worth it?
The short version of what Harbor offers is lowest-cost compounded GLP-1 with a 12-month money-back guarantee. It runs $99/month — toward the affordable end of the category, so cost isn't the reason to look elsewhere. It's a fairly plain, no-frills entry in the glp-1 providers category, without a lot of extra add-ons layered on top of the medication itself.
It is LegitScript-certified. It also offers round-the-clock messaging and refunds you if it doesn't work out.
How much Harbor actually costs
Compounded semaglutide runs $99/month and compounded tirzepatide runs $149/month.
That puts Harbor below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
bmiMD (about $99/month) is one of the closest alternatives to weigh Harbor against.
Medications: what Harbor prescribes
Harbor prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Harbor is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $99/month is below the roughly $169 median we track across the category.
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Harbor offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Harbor earns its place on the shortlist mainly on price: at $99/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Harbor scores best in our breakdown.
Ready to start with Harbor?
Starting at $99/month. See current pricing and start your free consultation.
Harbor might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Ro.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Harbor review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Harbor's current pricing
Plans start at $99/month. Start your free consultation to check eligibility and today's price.